NANOCOVAX is the Covid-19 vaccine candidate researched and developed by Nanogen based on recombinant DNA/protein technology. After having accomplished the pre-clinical trial with high safety and efficacy, Nano Covax is the first Covid-19 vaccine to be approved by Vietnam’s Ministry of Health to conduct clinical trial in Vietnam. Phase 1 of the clinical trial started on December 2020.
Products
